MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.76 -0.1 (-5.68%)	0.0 (0.0%)	0.0 (0.0%)	0.0 (0.0%)	---	---	-0.1 (-5.68%)	-0.1 (-5.68%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -18.4444
Diluted P/E:: -18.4444
RSI(14) 1m:: 53.97
VWAP:: 1.66
RVol:: 0.1016

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	2.01 +0.06 (+3.08%)	Oct 15 17:21
1m	Price increase 1m	2.01 +0.06 (+3.08%)	Oct 15 17:21
1m	Price increase 1m	2.01 +0.06 (+3.08%)	Oct 15 17:21
1m	Price increase 1m	2.01 +0.06 (+3.08%)	Oct 15 17:21
1m	Price increase 1m	2.01 +0.06 (+3.08%)	Oct 15 17:21